Evidence map›Paper›PMID 42282648›Full record

ArticlebioRxiv : the preprint server for biology2026

Modulation of Ferroptosis During Early

Joshua J Ivie, Sylvia Stull, Ethan Bustad, Courtney R Plumlee, Sara B Cohen, Fergal J Duffy, Alan H Diercks, John D Aitchison, Kevin B Urdahl, Alexis Kaushansky and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Joshua J IvieCenter for Global Infectious Disease Research, Seattle Children's Research Institute.ORCID 0000-0003-0116-1781
Sylvia StullCenter for Global Infectious Disease Research, Seattle Children's Research Institute.
Ethan BustadCenter for Global Infectious Disease Research, Seattle Children's Research Institute.
Courtney R PlumleeCenter for Global Infectious Disease Research, Seattle Children's Research Institute.
Sara B CohenCenter for Global Infectious Disease Research, Seattle Children's Research Institute.
Fergal J DuffyCenter for Global Infectious Disease Research, Seattle Children's Research Institute.
Alan H DiercksCenter for Global Infectious Disease Research, Seattle Children's Research Institute.
John D AitchisonCenter for Global Infectious Disease Research, Seattle Children's Research Institute.
Kevin B UrdahlCenter for Global Infectious Disease Research, Seattle Children's Research Institute.
Alexis KaushanskyCenter for Global Infectious Disease Research, Seattle Children's Research Institute.
Alissa C RothchildDepartment of Veterinary and Animal Sciences, University of Massachusetts Amherst.ORCID 0000-0001-7484-1193
Benjamin H GernCenter for Global Infectious Disease Research, Seattle Children's Research Institute.ORCID 0000-0002-0142-5970
Shuyi MaCenter for Global Infectious Disease Research, Seattle Children's Research Institute.

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH75N93019C00070 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI URDAHL, KEVIN · 2019 to 2025
$86.6M
Systems Biology CoreU19AI162598 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ALLAND, DAVID, ELLNER, JERROLD J. · 2021 to 2025
$13.9M
ACADEMIC PEDIATRIC INFECTIOUS DISEASET32HD007233 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI KEVIN B URDAHL · 1985 to 2026
$6.7M
Seattle Tuberculosis Research Advancement CenterP30AI168034 · NIAID · UNIVERSITY OF WASHINGTON · PI Rhea N Coler, CHETAN SESHADRI · 2022 to 2026
$6.3M
Network Dissection of Host-Pathogen Interactions in Mycobacterium tuberculosis InfectionDP2AI164249 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI MA, SHUYI · 2021 to 2025
$2.8M
Dissecting the molecular regulation of T cell localization and function within the Mycobacterium tuberculosis granulomaK08AI166072 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Benjamin Henry Gern · 2022 to 2026
$929k
NIAID NIH HHS DP2 AI164249NIAID NIH HHS K08 AI166072NIAID NIH HHS P30 AI168034NIAID NIH HHS U19 AI162598NICHD NIH HHS T32 HD007233NIH HHS 75N93019C00070
6 · The paper itself

Abstract

Although spread of internalized Mtb from the initial infected alveolar macrophages (AMs) is a crucial determinant of infection outcomes, the role of cell death in facilitating this spread, and how it is regulated by Mtb remains poorly understood. Ferroptosis, a lipid peroxidation-mediated form of necrotic cell death, contributes to pathology during later stages of infection. However, the role of ferroptosis in early AM cell death remains inadequately defined, and its induction during infection has been primarily studied with the laboratory strain, H37Rv. Using gene set variation analysis of single cell RNAseq data profiling Mtb-infected murine lungs, we found that the hypervirulent Beijing sublineage clinical strain SA161 is associated with an elevated pro-ferroptotic transcriptional response in AMs compared to H37Rv by 17 days post infection. Consistent with these transcriptional profiles, we found that SA161 induced increased lipid peroxidation in comparison to H37Rv during infection

Identifiers

PMID42282648
PMCPMC13252049

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.